Dual Antigen T Cell Engagers Targeting CA9 as an Effective Immunotherapeutic Modality for Targeting CA9 in Solid Tumors.

MLA

Tatari, Nazanin, et al. “Dual Antigen T Cell Engagers Targeting CA9 as an Effective Immunotherapeutic Modality for Targeting CA9 in Solid Tumors.” Frontiers in Immunology, vol. 13, July 2022, pp. 1–17. EBSCOhost, https://doi.org/10.3389/fimmu.2022.905768.

APA

Tatari, N., Xiaoyu Zhang, Chafe, S. C., McKenna, D., Lawson, K. A., Subapanditha, M., Shaikh, M. V., Seyfrid, M., Savage, N., Venugopal, C., Moffat, J., & Singh, S. K. (2022). Dual Antigen T Cell Engagers Targeting CA9 as an Effective Immunotherapeutic Modality for Targeting CA9 in Solid Tumors. Frontiers in Immunology, 13, 1–17. https://doi.org/10.3389/fimmu.2022.905768

Chicago

Tatari, Nazanin, Xiaoyu Zhang, Shawn C. Chafe, Dillon McKenna, Keith A. Lawson, Minomi Subapanditha, Muhammad Vaseem Shaikh, et al. 2022. “Dual Antigen T Cell Engagers Targeting CA9 as an Effective Immunotherapeutic Modality for Targeting CA9 in Solid Tumors.” Frontiers in Immunology 13 (July): 1–17. doi:10.3389/fimmu.2022.905768.